Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 779

1.

Correction to: Study Protocol for the Effects of Formula Diet with Dapagliflozin on Metabolic Improvement and Body Composition in Type 2 Diabetes Mellitus.

Watanabe Y, Kuribayashi N, Uchida D, Suzuki D, Kato M, Nagayama D, Ohashi H, Ohira M, Saiki A, Tatsuno I.

Diabetes Ther. 2020 Feb 12. doi: 10.1007/s13300-020-00757-6. [Epub ahead of print]

PMID:
32052282
2.

A Giant Gastric Gastrointestinal Stromal Tumor Successfully Resected Following Neoadjuvant Treatment With Imatinib Mesylate.

Takahashi R, Toyokawa T, Yoshii M, Tamura T, Tanaka H, Lee S, Muguruma K, Yashiro M, Ohira M.

Anticancer Res. 2020 Feb;40(2):1147-1152. doi: 10.21873/anticanres.14056.

PMID:
32014967
3.

Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties.

Terashima Y, Toda E, Itakura M, Otsuji M, Yoshinaga S, Okumura K, Shand FHW, Komohara Y, Takeda M, Kokubo K, Chen MC, Yokoi S, Rokutan H, Kofuku Y, Ohnishi K, Ohira M, Iizasa T, Nakano H, Okabe T, Kojima H, Shimizu A, Kanegasaki S, Zhang MR, Shimada I, Nagase H, Terasawa H, Matsushima K.

Nat Commun. 2020 Jan 30;11(1):609. doi: 10.1038/s41467-020-14338-5.

4.

Hepatic epithelioid hemangioendothelioma successfully treated with living donor liver transplantation: A case report and literature review.

Fukuhara S, Tahara H, Hirata Y, Ono K, Hamaoka M, Shimizu S, Hashimoto S, Kuroda S, Ohira M, Ide K, Kobayashi T, Ohdan H.

Clin Case Rep. 2019 Dec 17;8(1):108-115. doi: 10.1002/ccr3.2558. eCollection 2020 Jan.

5.

Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer.

Togano S, Yashiro M, Miki Y, Yamamato Y, Sera T, Kushitani Y, Sugimoto A, Kushiyama S, Nishimura S, Kuroda K, Okuno T, Yoshii M, Tamura T, Toyokawa T, Tanaka H, Muguruma K, Tanaka S, Ohira M.

PLoS One. 2020 Jan 15;15(1):e0225958. doi: 10.1371/journal.pone.0225958. eCollection 2020.

6.

Esophagectomy performed at institutes certified by the Japan Esophageal Society provide long-term survival advantages to esophageal cancer patients: second report analyzing 4897 cases with propensity score matching.

Motoyama S, Maeda E, Yano M, Yasuda T, Ohira M, Kajiyama Y, Higashi T, Doki Y, Matsubara H.

Esophagus. 2020 Jan 14. doi: 10.1007/s10388-019-00712-w. [Epub ahead of print]

PMID:
31939000
7.

Successful removal of a giant esophageal lipoma by thoracoscopic enucleation: a case report.

Goto W, Sakurai K, Kubo N, Tamamori Y, Maeda K, Ohira M.

Surg Case Rep. 2020 Jan 13;6(1):20. doi: 10.1186/s40792-020-0782-7.

8.

Biosynthesis of long chain base in sphingolipids in animals, plants and fungi.

Mashima R, Okuyama T, Ohira M.

Future Sci OA. 2019 Nov 14;6(1):FSO434. doi: 10.2144/fsoa-2019-0094. Review.

9.

Prognostic Significance of Neoadjuvant Rectal Score and Indication for Postoperative Adjuvant Therapy in Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy.

Maeda K, Shibutani M, Tachimori A, Nishii T, Aomatsu N, Fukuoka T, Nagahara H, Otani H, Inoue T, Ohira M.

In Vivo. 2020 Jan-Feb;34(1):283-289. doi: 10.21873/invivo.11772.

10.

An Incremental Sit-to-Stand Exercise for Evaluating Physical Capacity in Older Patients with Type 2 Diabetes.

Nakamura K, Nagasawa Y, Sawaki S, Yokokawa Y, Ohira M, Sato Y.

Tohoku J Exp Med. 2019 Dec;249(4):241-248. doi: 10.1620/tjem.249.241.

11.

The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer.

Yamamoto Y, Kuroda K, Sera T, Sugimoto A, Kushiyama S, Nishimura S, Togano S, Okuno T, Yoshii M, Tamura T, Toyokawa T, Tanaka H, Muguruma K, Ohira M, Yashiro M.

Anticancer Res. 2019 Dec;39(12):6645-6652. doi: 10.21873/anticanres.13879.

PMID:
31810929
12.

Marker Of Sepsis Severity Is Associated With The Variation In Cardio-Ankle Vascular Index (CAVI) During Sepsis Treatment.

Nagayama D, Imamura H, Endo K, Saiki A, Sato Y, Yamaguchi T, Watanabe Y, Ohira M, Shirai K, Tatsuno I.

Vasc Health Risk Manag. 2019 Nov 5;15:509-516. doi: 10.2147/VHRM.S228506. eCollection 2019.

13.

Gastric cancer cells alter the immunosuppressive function of neutrophils.

Hiramatsu S, Tanaka H, Nishimura J, Yamakoshi Y, Sakimura C, Tamura T, Toyokawa T, Muguruma K, Yashiro M, Hirakawa K, Ohira M.

Oncol Rep. 2020 Jan;43(1):251-259. doi: 10.3892/or.2019.7410. Epub 2019 Nov 20.

PMID:
31746403
14.

Successful Treatment of Chronic Myeloid Leukemia With Dasatinib After Kidney Transplantation: A Case Report.

Yamane H, Ide K, Tanaka A, Hashimoto S, Nagoshi H, Tahara H, Ohira M, Seidakhmetov A, Marlen D, Tanaka Y, Ohdan H.

Transplant Proc. 2019 Nov 13. pii: S0041-1345(19)30874-7. doi: 10.1016/j.transproceed.2019.06.006. [Epub ahead of print]

PMID:
31733802
15.

The clinicopathological significance of Thrombospondin-4 expression in the tumor microenvironment of gastric cancer.

Kuroda K, Yashiro M, Sera T, Yamamoto Y, Kushitani Y, Sugimoto A, Kushiyama S, Nishimura S, Togano S, Okuno T, Tamura T, Toyokawa T, Tanaka H, Muguruma K, Ohira M.

PLoS One. 2019 Nov 8;14(11):e0224727. doi: 10.1371/journal.pone.0224727. eCollection 2019.

16.

Successful Eradication of Helicobacter pylori Could Prevent Metachronous Gastric Cancer: A Propensity Matching Analysis.

Nakata R, Nagami Y, Hashimoto A, Sakai T, Ominami M, Fukunaga S, Otani K, Hosomi S, Tanaka F, Ohira M, Taira K, Yamagami H, Tanigawa T, Watanabe T, Fujiwara Y.

Digestion. 2019 Nov 1:1-10. doi: 10.1159/000504132. [Epub ahead of print]

PMID:
31678978
17.

Association of inflammatory biomarkers with long-term outcomes after curative surgery for mass-forming intrahepatic cholangiocarcinoma.

Ohira M, Yoshizumi T, Yugawa K, Kosai-Fujimoto Y, Inokuchi S, Motomura T, Mano Y, Toshima T, Itoh S, Harada N, Ikegami T, Soejima Y, Taketomi A, Mori M.

Surg Today. 2019 Oct 30. doi: 10.1007/s00595-019-01905-7. [Epub ahead of print]

PMID:
31667580
18.

CD133 and epithelial cell adhesion molecule expressions in the cholangiocarcinoma component are prognostic factors for combined hepatocellular cholangiocarcinoma.

Wakizaka K, Yokoo H, Kamiyama T, Kakisaka T, Ohira M, Tani M, Kato K, Fujii Y, Sugiyama K, Nagatsu A, Shimada S, Orimo T, Kamachi H, Matsuoka R, Taketomi A.

Hepatol Res. 2020 Feb;50(2):258-267. doi: 10.1111/hepr.13443. Epub 2019 Dec 18.

PMID:
31661725
19.

Cough Strength Is an Indicator of Aspiration Risk When Restarting Food Intake in Elderly Subjects With Community-Acquired Pneumonia.

Sakai Y, Ohira M, Yokokawa Y.

Respir Care. 2020 Feb;65(2):169-176. doi: 10.4187/respcare.07067. Epub 2019 Oct 15.

PMID:
31615924
20.

Adenoid Cystic Carcinoma of the Breast: A Case Report.

Kashiwagi S, Asano Y, Ishihara S, Morisaki T, Takashima T, Tanaka S, Amano R, Ohsawa M, Hirakawa K, Ohira M.

Case Rep Oncol. 2019 Sep 17;12(3):698-703. doi: 10.1159/000502949. eCollection 2019 Sep-Dec.

21.

Impact of certification status of the institute and surgeon on short-term outcomes after surgery for thoracic esophageal cancer: evaluation using data on 16,752 patients from the National Clinical Database in Japan.

Motoyama S, Yamamoto H, Miyata H, Yano M, Yasuda T, Ohira M, Kajiyama Y, Toh Y, Watanabe M, Kakeji Y, Seto Y, Doki Y, Matsubara H.

Esophagus. 2020 Jan;17(1):41-49. doi: 10.1007/s10388-019-00694-9. Epub 2019 Oct 3.

22.

Clinical Evaluation of Dynamic Monitoring of Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratios in Primary Endocrine Therapy for Advanced Breast Cancer.

Takada K, Kashiwagi S, Asano Y, Goto W, Takahashi K, Shibutani M, Amano R, Takashima T, Tomita S, Hirakawa K, Ohira M.

Anticancer Res. 2019 Oct;39(10):5581-5588. doi: 10.21873/anticanres.13752.

PMID:
31570453
23.

Management of Refractory Ascites for Liver Transplant Candidates: A Novel Cell-free and Concentrated Ascites Reinfusion Therapy.

Shimizu S, Ohira M, Nakano R, Imaoka Y, Sato K, Tahara H, Ide K, Kobayashi T, Kuroda S, Ono H, Tanaka Y, Ohdan H.

Transplant Proc. 2019 Oct;51(8):2740-2744. doi: 10.1016/j.transproceed.2019.02.060.

PMID:
31563243
24.

Everolimus enhances TRAIL-mediated anti-tumor activity of liver resident natural killer cells in mice.

Saparbay J, Tanaka Y, Tanimine N, Ohira M, Ohdan H.

Transpl Int. 2020 Feb;33(2):229-243. doi: 10.1111/tri.13536. Epub 2019 Oct 24.

PMID:
31560810
25.

Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status.

Ishihara S, Onoda N, Noda S, Asano Y, Tauchi Y, Morisaki T, Kashiwagi S, Takashima T, Ohira M.

Int J Oncol. 2019 Nov;55(5):1069-1076. doi: 10.3892/ijo.2019.4881. Epub 2019 Sep 19.

26.

Change in PMI During Neoadjuvant Therapy Is a Predictive Prognostic Marker in Rectal Cancer.

Fukuoka T, Maeda K, Nagahara H, Shibutani M, Iseki Y, Matsutani S, Hirakawa K, Ohira M.

Anticancer Res. 2019 Sep;39(9):5157-5163. doi: 10.21873/anticanres.13711.

PMID:
31519628
27.

Feasibility of Identifying Patients at High Risk of Hereditary Gastric Cancer Based on Clinicopathological Variables.

Nishimura S, Yashiro M, Sera T, Yamamoto Y, Kushitani Y, Sugimoto A, Kushiyama S, Kuroda K, Togano S, Okuno T, Tamura T, Toyokawa T, Tanaka H, Muguruma K, Hirakawa K, Ohira M.

Anticancer Res. 2019 Sep;39(9):5057-5064. doi: 10.21873/anticanres.13698.

PMID:
31519615
28.

Efficacy of Adjuvant Chemotherapy According to the Classification of Recurrence Risk Based on Systemic Inflammatory Markers in Patients With Liver Metastases of Colorectal Cancer.

Shibutani M, Nagahara H, Fukuoka T, Iseki Y, Hirakawa K, Ohira M.

Anticancer Res. 2019 Sep;39(9):5039-5045. doi: 10.21873/anticanres.13695.

PMID:
31519612
29.

[A Case of Lymph Node Recurrence Seven Years after Curative Esophagectomy for T1a(LPM)Upper Thoracic Esophageal Cancer].

Sasaki M, Tamura T, Toyokawa T, Sakurai K, Amano R, Kubo N, Tanaka H, Muguruma K, Yashiro M, Ohira M.

Gan To Kagaku Ryoho. 2019 Aug;46(8):1295-1297. Japanese.

PMID:
31501373
30.

Continuous intraoperative neuromonitoring for thyroid cancer surgery: A prospective study.

Onoda N, Noda S, Tauchi Y, Asano Y, Kusunoki Y, Ishihara S, Morisaki T, Kashiwagi S, Takashima T, Ohira M.

Laryngoscope Investig Otolaryngol. 2019 Jul 18;4(4):455-459. doi: 10.1002/lio2.290. eCollection 2019 Aug.

31.

C-reactive protein elevation ratio as an early predictor of postoperative severe complications after laparoscopic gastrectomy for gastric cancer: a retrospective study.

Tanaka H, Tamura T, Toyokawa T, Muguruma K, Kubo N, Sakurai K, Ohira M.

BMC Surg. 2019 Aug 20;19(1):114. doi: 10.1186/s12893-019-0582-9.

32.

Pure Mucinous Breast Carcinoma with Micropapillary Pattern (MUMPC): A Case Report.

Asano Y, Kashiwagi S, Nagamori M, Tanaka S, Kuwae Y, Amano R, Takashima T, Ohsawa M, Hirakawa K, Ohira M.

Case Rep Oncol. 2019 Jul 16;12(2):554-559. doi: 10.1159/000501766. eCollection 2019 May-Aug.

33.

TAp63 represses transcription of MYCN/NCYM gene and its high levels of expression are associated with favorable outcome in neuroblastoma.

Suenaga Y, Yamamoto M, Sakuma T, Sasada M, Fukai F, Ohira M, Yamaguchi Y, Yamamoto T, Ando K, Ozaki T, Nakagawara A.

Biochem Biophys Res Commun. 2019 Oct 15;518(2):311-318. doi: 10.1016/j.bbrc.2019.08.052. Epub 2019 Aug 17.

PMID:
31427086
34.

Alcohol Use Disorders Identification Test-consumption Predicts the Risk of Excessive Alcohol Consumption After Liver Transplantation.

Yano T, Ohira M, Sakamoto R, Narisada A, Shimizu S, Tahara H, Ide K, Kobayashi T, Imamura M, Machino A, Yamawaki S, Chayama K, Ohdan H.

Transplant Proc. 2019 Jul - Aug;51(6):1934-1938. doi: 10.1016/j.transproceed.2019.02.031.

PMID:
31399178
35.

The Effects of Eribulin on Breast Cancer Microenvironment Identified Using Eribulin-resistant Breast Cancer Cell Lines.

Goto W, Kashiwagi S, Asano Y, Takada K, Takahashi K, Fujita H, Takashima T, Shibutani M, Amano R, Tomita S, Hirakawa K, Ohira M.

Anticancer Res. 2019 Aug;39(8):4031-4041. doi: 10.21873/anticanres.13559.

PMID:
31366485
36.

Nationwide epidemiological survey of superficial hemosiderosis in Japan.

Ohira M, Takao M.

J Neurol Sci. 2019 Sep 15;404:106-111. doi: 10.1016/j.jns.2019.07.019. Epub 2019 Jul 17.

PMID:
31357133
37.

Fatty acid desaturase 2 is up-regulated by the treatment with statin through geranylgeranyl pyrophosphate-dependent Rho kinase pathway in HepG2 cells.

Tanaka S, Ishihara N, Suzuki S, Watanabe Y, Nagayama D, Yamaguchi T, Ohira M, Saiki A, Tanaka T, Tatsuno I.

Sci Rep. 2019 Jul 10;9(1):10009. doi: 10.1038/s41598-019-46461-9.

38.

Simultaneous Liver-Kidney Transplantation in Patient with a History of Heparin-Induced Thrombocytopenia: A Case Report and Literature Review.

Taguchi K, Ishiyama K, Ide K, Ohira M, Tahara H, Ohdan H.

Am J Case Rep. 2019 Jul 9;20:980-987. doi: 10.12659/AJCR.916717. Review.

39.

Verification of the effects of calcium channel blockers on the immune microenvironment of breast cancer.

Takada K, Kashiwagi S, Asano Y, Goto W, Takahashi K, Fujita H, Takashima T, Tomita S, Hirakawa K, Ohira M.

BMC Cancer. 2019 Jun 24;19(1):615. doi: 10.1186/s12885-019-5828-5.

40.

[Efficacy and Safety of Paclitaxel plus Ramucirumab Therapy for Unresectable or Recurrent Gastric Cancer].

Tsujio G, Toyokawa T, Fukuoka T, Tamura T, Ohira G, Shibutani M, Yamazoe S, Nagahara H, Kimura K, Amano R, Tanaka H, Muguruma K, Yashiro M, Maeda K, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2019 May;46(5):895-899. Japanese.

PMID:
31189811
41.

Prognostic Value of Quality of Life in Endocrine Therapy for Elderly Patients With Breast Cancer: A Retrospective Study.

Takada K, Kashiwagi S, Asano Y, Goto W, Takahashi K, Shibutani M, Amano R, Takashima T, Tomita S, Hirakawa K, Ohira M.

Anticancer Res. 2019 Jun;39(6):2941-2950. doi: 10.21873/anticanres.13424.

PMID:
31177133
42.

Postoperative Inflammation Is an Independent Prognostic Factor in Patients With Thoracic Esophageal Squamous Cell Carcinoma.

Toyokawa T, Tamura T, Sakurai K, Kubo N, Tanaka H, Muguruma K, Yashiro M, Ohira M.

Anticancer Res. 2019 Jun;39(6):2777-2784. doi: 10.21873/anticanres.13404.

PMID:
31177113
43.

Laparoscopic Sleeve Gastrectomy Significantly Increases Serum Lipoprotein Lipase Level in Obese Patients.

Ohira M, Yamaguchi T, Saiki A, Nakamura S, Tanaka S, Oka R, Watanabe Y, Sato Y, Oshiro T, Murano T, Tatsuno I.

Obes Facts. 2019;12(3):357-368. doi: 10.1159/000500360. Epub 2019 Jun 5.

44.

Validity and reproducibility of an incremental sit-to-stand exercise test in healthy middle-aged individuals.

Nagasawa Y, Nakamura K, Yokokawa Y, Ohira M.

J Phys Ther Sci. 2019 May;31(5):414-417. doi: 10.1589/jpts.31.414. Epub 2019 May 10.

45.

Utility of Doppler Ultrasonography in Liver Transplantation With Celiac Axis Compression Syndrome: A Case Report.

Mochizuki T, Ohira M, Hashimoto S, Tahara H, Ide K, Kobayashi T, Tanaka Y, Ohdan H.

Transplant Proc. 2019 Nov;51(9):3103-3106. doi: 10.1016/j.transproceed.2019.04.024. Epub 2019 May 30.

PMID:
31155307
46.

Risk Factors for Refractory Ascites After Living Donor Liver Transplant.

Sato K, Ohira M, Shimizu S, Imaoka Y, Hashimoto S, Tahara H, Kobayashi T, Kuroda S, Ide K, Tanaka Y, Ohdan H.

Transplant Proc. 2019 Jun;51(5):1516-1519. doi: 10.1016/j.transproceed.2019.01.120.

PMID:
31155185
47.

Unusual Aorto-mitral Discontinuity Caused by Infective Endocarditis.

Nakagawa T, Mori M, Tada H, Ohira M, Iino K, Hayashi K, Takemura H, Yamagishi M, Kawashiri MA.

Intern Med. 2019 Aug 15;58(16):2373-2376. doi: 10.2169/internalmedicine.2629-19. Epub 2019 May 22.

48.

Clinical Outcomes of Recombinant Human-soluble Thrombomodulin Treatment for Disseminated Intravascular Coagulation in Solid Tumors.

Kashiwagi S, Asano Y, Takahashi K, Shibutani M, Amano R, Tomita S, Hirakawa K, Ohira M.

Anticancer Res. 2019 May;39(5):2259-2264. doi: 10.21873/anticanres.13342. Review.

PMID:
31092417
49.

Predictive factors of difficulty of thoracoscopic esophagectomy in the left decubitus position.

Fujiwara Y, Lee S, Gyobu K, Inazu D, Naka R, Nishiyama M, Ohira M, Osugi H.

Esophagus. 2019 Jul;16(3):316-323. doi: 10.1007/s10388-019-00663-2. Epub 2019 Apr 30.

PMID:
31041586
50.

A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy.

Katsuda M, Miyazawa M, Ojima T, Katanuma A, Hakamada K, Sudo K, Asahara S, Endo I, Ueno M, Hara K, Yamada S, Fujii T, Satoi S, Ioka T, Ohira M, Akahori T, Kitano M, Nagano H, Furukawa M, Adachi T, Yamaue H.

Trials. 2019 Apr 27;20(1):242. doi: 10.1186/s13063-019-3332-5.

Supplemental Content

Support Center